Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4A | O75164 | 4/20 | 0.49 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.47 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.47 |
| ▸ | APP | P05067 | 3/20 | 0.47 |
| ▸ | INSR | P06213 | 1/20 | 0.39 |
| ▸ | CHAT | P28329 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18493455 | 1.00 | KDM4A (0.49) | KDM4AKDM2ACHRM2CHRM4CHRM5 | |
| SCHEMBL83585 | 0.96 | CHRM2 (0.52) | KDM4AKDM2ACHRM2CHRM4CHRM5 | |
| SCHEMBL4298270 | 0.96 | CHRM2 (0.52) | KDM4AKDM2ACHRM2CHRM4CHRM5 | |
| Water SCHEMBL22655270 | 0.95 | CHRM2 (0.51) | KDM4AKDM2ACHRM2CHRM4CHRM5 | |
| Water SCHEMBL22655271 | 0.95 | CHRM2 (0.51) | KDM4AKDM2ACHRM2CHRM4CHRM5 | |
| SCHEMBL25174360 | 0.91 | CHRM2 (0.57) | KDM4AKDM2ACHRM2CHRM4CHRM5 | |
| SCHEMBL9016124 | 0.91 | CHRM2 (0.57) | KDM4AKDM2ACHRM2CHRM4CHRM5 | |
| SCHEMBL6418098 | 0.91 | CHRM2 (0.57) | KDM4AKDM2ACHRM2CHRM4CHRM5 | |
| SCHEMBL9016121 | 0.91 | CHRM2 (0.57) | KDM4AKDM2ACHRM2CHRM4CHRM5 | |
| SCHEMBL6418092 | 0.91 | CHRM2 (0.57) | KDM4AKDM2ACHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014561-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | UNIV WASHINGTON (US) | 2026-01-15 | — | — | US | disclosed |
| US-12447469-B2 | Methods and apparatus for single biological nanoparticle analysis | UNIVERSITY OF WASHINGTON (US) | 2025-10-21 | — | — | US | disclosed |
| US-20240374214-A1 | IMPLANTABLE AND CONTINUOUS MULTI-ANALYTE MONITOR (MAM) SENSOR | UNIV CALIFORNIA (US) | 2024-11-14 | — | — | US | disclosed |
| US-20230251194-A1 | OPTICAL ANALYSES OF PARTICLES AND VESICLES | SCINTILLON INSTITUTE FOR BIOMEDICAL AND BIOENERGY RESEARCH | 2023-08-10 | — | — | US | disclosed |
| WO-2023039393-A1 | IMPLANTABLE AND CONTINUOUS MULTI-ANALYTE MONITOR (MAM) SENSOR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-03-16 | — | — | WO | disclosed |
| US-11486829-B2 | Optical analyses of particles and vesicles | SCINTILLON INSTITUTE FOR BIOMEDICAL AND BIOENERGY RESEARCH (US) | 2022-11-01 | — | — | US | disclosed |
| EP-3775838-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | University of Washington (US) | 2021-02-17 | — | — | EP | disclosed |
| US-20210016276-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | UNIVERSITY OF WASHINGTON (US) | 2021-01-21 | — | — | US | disclosed |
| US-20200173923-A1 | OPTICAL ANALYSES OF PARTICLES AND VESICLES | SCINTILLON INSTITUTE FOR BIOMEDICAL AND BIOENERGY RESEARCH | 2020-06-04 | — | — | US | disclosed |
| WO-2019199499-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | UNIVERSITY OF WASHINGTON (US) | 2019-10-17 | — | — | WO | disclosed |
| US-10429302-B2 | Optical analyses of particles and vesicles | SCINTILLON INSTITUTE FOR BIOMEDICAL AND BIOENERGY RESEARCH (US) | 2019-10-01 | — | — | US | disclosed |
| EP-3335028-A1 | OPTICAL ANALYSES OF PARTICLES AND VESICLES | Scintillon Institute for Biomedical and Bioenergy Research (US) | 2018-06-20 | — | — | EP | disclosed |
| WO-2017027622-A1 | OPTICAL ANALYSES OF PARTICLES AND VESICLES | SCINTILLON INSTITUTE FOR BIOMEDICAL AND BIOENERGY RESEARCH (US) | 2017-02-16 | — | — | WO | disclosed |
| US-20170045451-A1 | OPTICAL ANALYSES OF PARTICLES AND VESICLES | SCINTILLON INSTITUTE FOR BIOMEDICAL AND BIOENERGY RESEARCH | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014561-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | CD63, SELL, LAMP2 | KDM4A 4694/4885KDM2A 4203/4885CHRM2 2652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.